(Q43622759)

25 November 2017

Relationship of p15 and p16 gene alterations to elevated dihydrofolate reductase in childhood acute lymphoblastic leukaemia (English)

1 reference

25 November 2017

1 reference

Shah SJ

1

1 reference

25 November 2017

Taub JW

2

1 reference

25 November 2017

Witt TL

3

1 reference

25 November 2017

Pollock BH

4

1 reference

25 November 2017

Ding BC

5

1 reference

25 November 2017

Moore DS

6

1 reference

25 November 2017

Amylon M

7

1 reference

25 November 2017

Pullen J

8

1 reference

25 November 2017

Ravindranath Y

9

1 reference

25 November 2017

Matherly LH

10

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

British Journal of Haematology

25 November 2017

1 reference

25 November 2017

113

1 reference

25 November 2017

3

1 reference

25 November 2017

746-756

1 reference

Rapid, simultaneous measurement of DNA, protein, and cell volume in single cells from large mammalian cell populations

25 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Shortened survival after relapse in T-cell acute lymphoblastic leukemia patients with p16/p15 deletions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

The cellular pharmacology of methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Intrinsic and acquired resistance to methotrexate in acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Effect of cyclin D1 overexpression on drug sensitivity in a human fibrosarcoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

A cell cycle regulator potentially involved in genesis of many tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Deregulated expression of E2F family members induces S-phase entry and overcomes p16INK4A-mediated growth suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Methotrexate pharmacology and resistance in childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Expression and prognostic value of the retinoblastoma tumour suppressor gene (RB-1) in childhood acute lymphoblastic leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Effects of exogenous p16INK4a on growth of cells with various status of cell-cycle regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

Gene amplification and increased expression of the reduced folate carrier in transport elevated K562 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

P53 mutation in acute T cell lymphoblastic leukemia is of somatic origin and is stable during establishment of T cell acute lymphoblastic leukemia cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.02775.X

10.1046/J.1365-2141.2001.02775.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference